Does BENDAMUSTINE Cause Myelosuppression? 305 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Myelosuppression have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 1.6% of all adverse event reports for BENDAMUSTINE.
305
Reports of Myelosuppression with BENDAMUSTINE
1.6%
of all BENDAMUSTINE reports
42
Deaths
138
Hospitalizations
How Dangerous Is Myelosuppression From BENDAMUSTINE?
Of the 305 reports, 42 (13.8%) resulted in death, 138 (45.2%) required hospitalization, and 24 (7.9%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for BENDAMUSTINE.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which BENDAMUSTINE Alternatives Have Lower Myelosuppression Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE